AGIOS PHARMACEUTICALS, INC. Increase (Decrease) in Income Taxes Payable
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Increase (Decrease) in Income Taxes Payable of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2026-07-30
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in income taxes payable for the quarter ending 2026-06-30 was $0.00.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in income taxes payable for the quarter ending 2026-03-31 was $0.00.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in income taxes payable for the quarter ending 2025-12-31 was $0.00.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in income taxes payable for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in income taxes payable for fiscal 2025 was -$871.00K, a 200.00% decline from fiscal 2024.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in income taxes payable for fiscal 2024 was $871.00K.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in income taxes payable for fiscal 2023 was $0.00.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in income taxes payable for fiscal 2022 was $0.00.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $0.00 10-Q · filed 2026-07-30 | $0.00 derived: sum of 3 quarters · filed 2026-07-30 | $0.00 derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $0.00 10-Q · filed 2026-04-29 | $0.00 derived: sum of 2 quarters · filed 2026-04-29 | $0.00 derived: sum of 3 quarters · filed 2026-04-29 | -$683.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | -$683.00K derived: sum of 3 quarters · filed 2026-07-30 | -$871.00K 10-K · filed 2026-02-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$683.00K derived: sum of 2 quarters · filed 2026-07-30 | -$871.00K 10-Q · filed 2025-10-30 | -$52.68M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$683.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$871.00K 10-Q · filed 2026-07-30 | -$52.68M derived: sum of 3 quarters · filed 2026-07-30 | $0.00 derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$188.00K 10-Q · filed 2026-04-29 | -$52.00M derived: sum of 2 quarters · filed 2026-04-29 | $683.00K derived: sum of 3 quarters · filed 2026-04-29 | $683.00K derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | -$51.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $871.00K derived: sum of 2 quarters · filed 2026-02-12 | $871.00K derived: sum of 3 quarters · filed 2026-02-12 | $871.00K 10-K · filed 2026-02-12 |
| 2024-09-30 | $52.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $52.68M derived: sum of 2 quarters · filed 2025-10-30 | $52.68M 10-Q · filed 2025-10-30 | $52.68M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $0.00 10-Q · filed 2025-07-31 | $0.00 derived: sum of 3 quarters · filed 2026-02-12 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-01 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $0.00 10-K · filed 2026-02-12 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-10-31 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-13 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-02-14 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $0.00 derived: sum of 2 quarters · filed 2018-02-14 | $0.00 derived: sum of 3 quarters · filed 2018-02-14 | $3.84M 10-K · filed 2018-02-14 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $3.84M 10-Q · filed 2016-11-03 | $3.84M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $3.84M 10-Q · filed 2016-08-08 | $3.84M derived: sum of 3 quarters · filed 2017-02-16 | $3.84M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-03-31 | $3.84M 10-Q · filed 2016-05-09 | $3.84M derived: sum of 2 quarters · filed 2017-02-16 | $3.84M derived: sum of 3 quarters · filed 2017-02-16 | $4.50M derived: sum of 4 quarters · filed 2017-02-16 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $0.00 derived: sum of 2 quarters · filed 2017-02-16 | $655.00K derived: sum of 3 quarters · filed 2017-02-16 | -$5.30M 10-K · filed 2017-02-16 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $655.00K derived: sum of 2 quarters · filed 2015-11-06 | -$5.30M 10-Q · filed 2015-11-06 | -$8.99M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $655.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$5.30M 10-Q · filed 2015-08-07 | -$8.99M derived: sum of 3 quarters · filed 2016-02-26 | -$8.87M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | -$5.96M 10-Q · filed 2015-05-11 | -$9.64M derived: sum of 2 quarters · filed 2016-02-26 | -$9.53M derived: sum of 3 quarters · filed 2016-02-26 | -$9.44M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | -$3.68M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$3.57M derived: sum of 2 quarters · filed 2016-02-26 | -$3.48M derived: sum of 3 quarters · filed 2016-02-26 | -$3.30M 10-K · filed 2016-02-26 |
| 2013-09-30 | $116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $206.00K derived: sum of 2 quarters · filed 2014-11-07 | $382.00K 10-Q · filed 2014-11-07 | -$2.69M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $266.00K 10-Q · filed 2014-08-07 | -$2.80M derived: sum of 3 quarters · filed 2015-02-24 | -$4.72M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $176.00K 10-Q · filed 2014-05-09 | -$2.89M derived: sum of 2 quarters · filed 2015-02-24 | -$4.81M derived: sum of 3 quarters · filed 2015-02-24 | |
| 2012-12-31 | -$3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$4.99M derived: sum of 2 quarters · filed 2015-02-24 | -$12.99M 10-K · filed 2015-02-24 | |
| 2012-09-30 | -$1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$9.93M 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | -$8.01M 10-Q · filed 2013-09-05 | |||
| 2011-12-31 | $17.87M 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |